Injection
Tesamorelin
A peptide that targets stubborn abdominal fat and supports a leaner body composition, prescribed and monitored by a licensed clinician.
Starting at $179/mo
Research peptideGut healthOral
BPC-157 Oral Capsules
RxPrescription onlyTaken by mouth · Once a day · 500 mcg · Research peptide · Gut health · Oral
Starting at $129/mo
BPC-157 oral 500 mcg: body-protection peptide for GI healing, gastritis, IBS, and intestinal barrier support. One capsule daily with food. Off-label; preclinical evidence strong, human oral data limited.
How many capsules per month?
MonthlyEvery 3 months
30 capsulesper month
You'll receive 30 capsules per month. $149 billed monthly. Cancel anytime.
Real prices from our pharmacy. Longer plans cost less per month and are billed up front. Pause or cancel anytime.
- Studied for GI healing and gastric ulcer recovery
- Supports intestinal barrier and reduces inflammation
- Oral capsule; no injection required
Every plan includes
- Personalized, physician-guided plan
- 30 capsules per month, monthly and 3-month
- Dispensed by a US-licensed compounding pharmacy
- Unlimited protocol adjustments and messaging
- Ongoing support and check-ins
- Pause or cancel anytime
- Reviewed by our in-house physicians
- Physician-guided care
- Ongoing, expert support
- 100% online
- Free, discreet shipping
What is BPC-157 oral?
(body-protection peptide, oral form)
BPC-157 is a peptide discovered in gastric juice, named the 'body-protection peptide' for its broad tissue-protective effects. Oral BPC-157 (500 mcg per capsule) is studied for gastritis, ulcers, IBS, and leaky gut. It is thought to work by supporting blood vessel growth, reducing inflammation, and strengthening the intestinal barrier. Taken as one capsule daily with food, oral BPC-157 reaches the gut directly.
- How it is taken
- Taken by mouth
- How often
- Once a day
- Dose range
- 500 mcg
- Form
- Research peptide · Gut health · Oral
Preclinical
strong GI healing evidence; limited human oral data
BPC-157 is prescribed off-label for gut health based on preclinical support and clinical experience. Oral bioavailability is not fully understood; effects may take 4–8 weeks to appear.
How it works,
week by week.
Week 1
A US-licensed physician reviews your GI symptoms (gastritis, ulcers, IBS, bloating), medical history, and medications. Discusses how BPC-157 supports gut healing and the evidence gaps.
Weeks 1–2
Start with one 500 mcg capsule daily with food. Most people tolerate it well; digestive changes (loose stool, bloating) are common but usually brief.
Weeks 3–4
Digestive symptoms may begin to ease: less bloating, improved regularity, or reduced pain. Some notice changes within days; others take 4–6 weeks. Keep a symptom diary.
Month 2
Your physician checks in, reviews your symptom diary, and confirms improvement. Discuss any changes in pain, bloating, energy, or digestion.
Beyond
BPC-157 works best with consistent daily use. Your physician monitors your response at each check-in and adjusts duration based on your healing progress.
What you may notice,
and when.
Reduced inflammation
less bloating, cramping, and gut irritation
Faster healing
ulcers or gastritis resolve more quickly
Better digestion
smoother bowel regularity and less pain
Time required
gut healing takes weeks; consistent use is key
Individual results vary. Benefits reflect what Zepym Health members commonly report to their physician at check-ins; they are not the results of a clinical trial.
Safety first:
what to know before you start.
Important safety information and common side effects
BPC-157 oral is generally well tolerated. The most common mild effects are digestive changes (loose stools, mild bloating, or appetite changes) in the first 1–2 weeks, usually self-limiting. Because BPC-157 supports blood vessel growth, it is not prescribed with active bleeding, recent surgery (within 2 weeks), or on anticoagulants (warfarin, apixaban) without careful discussion—your physician may monitor clotting. It is not prescribed during pregnancy or breastfeeding. Tell your physician about every medication, especially blood thinners or GI medications (PPIs, H2 blockers). Stop and seek care for signs of GI bleeding (black stools, vomiting blood), severe abdominal pain, or signs of allergic reaction.
The research behind
BPC-157.
A 15-amino-acid peptide from a gastric protein. Almost all of the evidence is from rodent and other animal studies; human data are a handful of small, uncontrolled reports.
- Human studies3 pilot studies
A 2025 review found only three human pilot studies: intra-articular knee pain, interstitial cystitis and an intravenous safety study. None is a controlled trial of tendon, muscle or bone healing.
Review of BPC-157 for musculoskeletal healing, PMC 2025 - Intravenous safety2 participants
A pilot study gave two healthy adults infusions of up to 20 mg. No measurable change in heart, liver, kidney, thyroid or glucose markers was seen, and no side effects were reported. Two people cannot establish safety.
Safety of intravenous infusion of BPC157 in humans: a pilot study, Europe PMC - Animal dataanimal data only
Rodent and other animal studies of tendon transection, muscle crush and bone fracture report faster healing. Most of this work comes from one research group in Croatia.
Review of BPC-157 for musculoskeletal healing, PMC 2025
What the studies found
- No benefit has been shown in people. Animal studies of tendon cuts, muscle crush and bone fracture report faster healing (review, PMC 2025).
- The only human data are three pilot studies without a controlled efficacy outcome, so no human benefit is established (review, PMC 2025).
- Cell and animal work reports protective effects on the stomach lining, gut and blood vessels after injury; these are unproven in people (2026 review of BPC-157).
No published human study has measured how BPC-157 behaves in people at the doses sold here. Research-grade and compounded versions were not the ones studied in animals or in the few human reports.
What this does not say
- No controlled human trial shows that BPC-157 heals tendons, muscles, bone or gut tissue.
- FDA's list of bulk drug substances that may present significant safety risks describes compounded BPC-157 as carrying immunogenicity risk, with limited safety data for the proposed routes. The entry is among withdrawn nominations and the compounding rules have changed, so check the FDA page before relying on it.
- The brand products are not the compounded versions described by FDA and the reviews. Oral capsules were not studied in people.
The research
behind it.
BPC-157 accelerates ulcer healing, reduces gastric inflammation, and supports blood vessel growth in animal models. Oral administration delivers the peptide directly to the GI tract.
Human oral data are very limited. Your physician explains the evidence gap and monitors your GI symptoms at check-ins. A symptom diary (bloating, pain, bowel regularity) helps track response.
Getting started
takes a few minutes.
- 1
Connect with a physician
Answer a few questions online and a US-licensed physician reviews your health, history and goals to make sure treatment is right for you. 100% online. No in-person visit required.
- 2
Get your discreet shipment
If approved, your treatment is compounded by a US-licensed, LegitScript-certified pharmacy, inspected for quality, and shipped discreetly to your door.
- 3
Receive continuous support
Start with one goal, then keep building over time. Unlimited physician messaging, easy refills and dose adjustments, all from the Zepym Health app.
Frequently asked questions
Contact supportHow do I take BPC-157 Capsules?
Taken by mouth, once a day. The starting prescription is 1 capsule (500 mcg) each time. Your physician sets your own dose and it is printed on your label.
How much arrives in each shipment?
30 capsules at the starting strength, shipped to your door from a licensed US pharmacy.
How do I take BPC-157 oral?
Take one 500 mcg capsule daily with food. Consistency matters—same time each day, every day. Effects may take 4–8 weeks to notice; some people feel better sooner, others need longer. Keep a food and symptom diary to track any improvements in bloating, pain, or digestion.
How long until my GI symptoms improve?
Some people notice relief within 1–2 weeks; others take 4–8 weeks. Consistency is crucial—take the capsule every day with food. Keep a detailed symptom diary: note bloating, pain, stool regularity, and energy. Small improvements often precede major shifts.
Can I take BPC-157 with my other GI medications?
Tell your physician about all medications, especially antacids, PPIs (proton pump inhibitors), H2 blockers, or laxatives. Most combinations are compatible, but timing may matter—your physician advises spacing or timing changes.
What if my symptoms don't improve?
Gut healing takes time. After 8–10 weeks of consistent use with no improvement, your physician may increase the dose, try a different formulation, or explore whether BPC-157 is the right fit. Some gut issues require additional interventions (dietary changes, stress management).
Can I take BPC-157 long-term?
Oral BPC-157 can be used long-term for ongoing gut support. Your physician may recommend taking it for 8–12 weeks, pausing to assess, and resuming if needed. Many people find a maintenance dose helpful once their gut heals significantly.
BPC-157 Oral educational content reviewed by our physician
Scott Nass, MD Doctor of Medicine, board-certified in Family Medicine
Charles R. Drew University and David Geffen School of Medicine at UCLA. Family Medicine residency at Ventura County Medical Center.
More options
in this area.
Troche
Sermorelin Troches
The same growth hormone-releasing peptide as a dissolving troche, for people who would rather skip injections.
30 troches per month
Starting at $209/mo
Injection
CJC-1295 / Ipamorelin
Two peptides that prompt your pituitary to release your own growth hormone, used for deeper sleep, recovery and body composition. Prescribed and dosed by a licensed physician.
Starting at $229/mo
Injection
BPC-157
A peptide studied for tissue repair and recovery, used to support healing of muscle, tendon and gut after injury or hard training. Prescribed and dosed by a licensed physician.
Starting at $209/mo
References
- 1.BPC-157: A neuropeptide with diverse physiological effects in animal models and emerging human applications. Peptides, 2017
- 2.BPC-157 in inflammatory bowel disease: mechanisms and emerging therapeutic potential. Pharmacol Res, 2020
Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. Products are compounded by a licensed pharmacy. The FDA has not reviewed or approved compounded products for any use for safety, efficacy, or quality. Compounded medications are not FDA-approved brand-name products.